| Title |
Author |
Type |
Date |
Words |
| Clinical effect of decitabine in the treatment of myelodysplastic syndrome and influencing factors. |
Tangxia Liu, Jing Wang, Chunmei Li and Lingzhi Jia |
|
Aug 8, 2020 |
3194 |
| Philhealth chief Morales told to go on leave due to lymphoma, chemotherapy. |
|
|
Aug 8, 2020 |
300 |
| GlaxoSmithKline receives green light for bone marrow cancer drug. |
|
|
Aug 7, 2020 |
248 |
| Roche Secures European Approval For Rozlytrek Cancer Drug. |
|
|
Aug 3, 2020 |
165 |
| Roche In US Breakthrough Status For Cancer Drug; Teams With Blueprint. |
|
|
Jul 14, 2020 |
374 |
| Clinigen Gets US Orphan Drug Designation For ALS Treatment Aldesleukin. |
|
|
Jul 13, 2020 |
212 |
| Breast cancer medication breakthrough. |
|
|
Jul 7, 2020 |
160 |
| Daiichi Sankyo Company reports EMA's accelerated assessment for trastuzumab feruxtecan for HER2 positive metastatic breast cancer. |
|
|
Jul 6, 2020 |
254 |
| Daiichi Sankyo Company reports EMA's accelerated assessment for trastuzumab feruxtecan for HER2 positive metastatic breast cancer. |
|
|
Jul 6, 2020 |
258 |
| The expanding role of biomarker testing in non-small cell lung cancer. |
Vennapusa, Bharathi |
|
Jul 1, 2020 |
1948 |
| Proapoptotic and Antiangiogenic Activities of Arctium Lappa L. on Breast Cancer Cell Lines. |
Agha, Mohamad Taleb; Baharetha, Hussein M.; Al-Mansoub, Majed Ahmed; Tabana, Yasser M.; Aziz, Nur Hi |
|
Jun 30, 2020 |
9395 |
| Merck KGaA, Pfizer Complete Bladder Cancer Drug Application In Europe. |
|
|
Jun 22, 2020 |
175 |
| Revolution Medicines gives R&D update on novel targeted cancer therapies. |
|
|
Jun 22, 2020 |
173 |
| New cancer drug created; Health: Aberdeen University scientists in pioneering work to tackle disease. |
NEIL DRYSDALE |
|
Jun 20, 2020 |
423 |
| Genprex ramps up production of active agent for its lung cancer drug Oncoprex. |
|
|
Jun 17, 2020 |
335 |
| Experimental Cancer Drug May Treat Devastating Genetic Illness. |
|
|
Jun 15, 2020 |
242 |
| Alphamab Oncology partners with Sanofi for studying Taxotere and KN026 combination in treating HER2+ breast cancer. |
|
|
Jun 9, 2020 |
238 |
| Alphamab Oncology partners with Sanofi for studying Taxotere and KN026 combination in treating HER2+ breast cancer. |
|
|
Jun 9, 2020 |
234 |
| YouTube vlogger Emman Nimedez begins chemotherapy for leukemia. |
|
|
Jun 3, 2020 |
375 |
| Cytopenia among CML Patients on Imatinib in Kenya: Types, Grades, and Time Course. |
McLigeyo, Angela; Rajab, Jamilla; Ezzi, Mohammed; Oyiro, Peter; Bett, Yatich; Odhiambo, Andrew; Ongo |
|
May 31, 2020 |
3132 |
| Using Topomer Comparative Molecular Field Analysis to Elucidate Activity Differences of Aminomethylenethiophene Derivatives as Lysyl Oxidase Inhibitors: Implications for Rational Design of Antimetastatic Agents for Cancer Therapy. |
Han, Jing; Yan, Guochao; Feng, Jianping; Yang, Xianglin; Zhou, Yuan |
|
May 31, 2020 |
3387 |
| Chitosan-Based Nanoparticles for Intracellular Delivery of ISAV Fusion Protein cDNA into Melanoma Cells: A Path to Develop Oncolytic Anticancer Therapies. |
Robles-Planells, Claudia; Sanchez-Guerrero, Giselle; Barrera-Avalos, Carlos; Matiacevich, Silvia; Ro |
|
May 31, 2020 |
6711 |
| Syncona says investee firm starts trials for new +personalised' skin cancer therapy. |
|
|
May 30, 2020 |
300 |
| Syncona Investee Achilles Therapeutics Starts Melanoma Therapy Trial. |
|
|
May 29, 2020 |
281 |
| Iovance presents data for TIL therapy lifileucel in advanced melanoma at ASCO. |
|
|
May 29, 2020 |
241 |
| WCM-Q scientists modify bacteria cells to deliver anti-cancer drugs. |
|
|
May 29, 2020 |
572 |
| WCM-Q researchers help reprogram bacteria cells to deliver anti-cancer drugs. |
|
|
May 28, 2020 |
638 |
| Prostate cancer: Breast cancer drug olaparib has the potential to be the world's first precision medicine for prostate cancer, writes Amy Packer. |
Amy Packer |
|
May 26, 2020 |
1142 |
| PROSTATE CANCER: the new hope; Breast cancer drug olaparib has the potential to be the world's first precision medicine for prostate cancer, writes. |
AMY PACKER |
|
May 26, 2020 |
1156 |
| Current Approach to Neutropenic Enterocolitis. |
Erturk, Umran Sumeyse; Turak, Esra Ermis; Kaynar, Leylagul; Fadel, Elias |
|
May 21, 2020 |
1352 |
| Appeal trial for fake cancer drugs case at VN Pharma starts. |
|
|
May 18, 2020 |
445 |
| Rising Pharmaceuticals, Laurus Labs to Support a Phase 2 Randomized Clinical Trial of Hydroxychloroquine for Prophylaxis Against COVID-19 in Patients Receiving Cancer Therapy. |
|
|
May 7, 2020 |
385 |
| US FDA approves NJ Novartis Pharmaceuticals' Tabrecta lung cancer drug. |
|
|
May 7, 2020 |
233 |
| US FDA approves NJ Novartis Pharmaceuticals' Tabrecta lung cancer drug. |
|
|
May 7, 2020 |
237 |
| Current Approaches for Personalized Therapy of Soft Tissue Sarcomas. |
Kirsanov, Kirill I.; Lesovaya, Ekaterina A.; Fetisov, Timur I.; Bokhyan, Beniamin Yu; Belitsky, Genn |
|
Apr 30, 2020 |
11703 |
| A Case Report with Severe Thrombocytopenia Induced by Axitinib. |
Koksal, Ulkuhan I.; Goffin, Janeiro Valle; Lewis, Brian; Sartor, Oliver A.; Belyaeva, Elizaveta; Soc |
|
Apr 30, 2020 |
2568 |
| A Case of Cardiac Tamponade in a Patient with Metastatic Renal Cell Carcinoma on Pazopanib Treatment. |
Sarathy, Vinu; Jayappa, Sriniivas Belagutty; Waran, Thianesh; Naik, Radheshyam |
|
Apr 30, 2020 |
1486 |
| ctDNA Detection in Microfluidic Platform: A Promising Biomarker for Personalized Cancer Chemotherapy. |
Gauri, Samla; Ahmad, Mohd R. |
|
Apr 30, 2020 |
6908 |
| Low-Dose Decitabine Assists Human Umbilical Cord-Derived Mesenchymal Stem Cells in Protecting Cells via the Modulation of the Macrophage Phenotype in Type 2 Diabetic Mice. |
Xue, Jing; Cheng, Yu; Hao, Haojie; Gao, Jieqing; Yin, Yaqi; Yu, Songyan; Zou, Junyan; Liu, Jiejie; Z |
|
Apr 30, 2020 |
8362 |
| Pharmaxis cancer drug ready to start myelofibrosis phase 2 studies this year. |
|
|
Apr 29, 2020 |
740 |
| Experimental cancer drug could stop coronavirus in its tracks, scientists claim; Scientists from the University of Louisville have developed a technology that they believe could stop the virus from infecting human cells. |
By, Shivali Best |
|
Apr 27, 2020 |
273 |
| CNS Pharmaceuticals Files for FDA Orphan Drug Designation for Brain Cancer Drug Berubicin. |
|
|
Apr 27, 2020 |
444 |
| AstraZeneca cancer drug passes prostate trial milestone. |
|
|
Apr 25, 2020 |
221 |
| TRACON Pharmaceuticals retains rights to prostate cancer drug candidate, targets China for commercialization. |
|
|
Apr 25, 2020 |
474 |
| Keeping active is the best prostate cancer medicine. |
DR MIRIAM STOPPARD |
|
Apr 21, 2020 |
452 |
| Potential cancer drug in willows. |
|
|
Apr 16, 2020 |
168 |
| Potential cancer drug in willows. |
|
|
Apr 16, 2020 |
168 |
| AstraZenecaAato trial blood cancer drug for coronavirus treatment. |
|
|
Apr 15, 2020 |
440 |
| AstraZenecaAato trial blood cancer drug for coronavirus treatment. |
|
|
Apr 15, 2020 |
442 |
| Cancer drug could protect people from worst effects of Covid-19; A global clinical trial will now be launched into the power of Calquence. |
By, Neil Shaw |
|
Apr 14, 2020 |
164 |
| Examining the Early Period Effect of Nilotinib on Hearing: An Experimental Study. |
Bora, Adem; Durmus, Kasim; Terzi, Hatice; Altuntas, Emine Elif |
Report |
Apr 1, 2020 |
7853 |
| Giant Primary Retroperitoneal Serous Cystadenoma: A Rare Entity Mimicking Multiple Neoplastic and Nonneoplastic Processes. |
Chen, Fengming; Jiang, Kun |
|
Apr 1, 2020 |
3527 |
| Neoplastic patients' knowledge about intestinal parasitoses in southern Brazil/Conhecimento de pacientes neoplasicos sobre parasitoses intestinais no sul do Brasil. |
Jeske, S.; Bianchi, T.F.; Leon, I.F.; Villela, M.M. |
|
Apr 1, 2020 |
5580 |
| Dual HER2 Blockade versus a Single Agent in Trastuzumab-Containing Regimens for HER2-Positive Early Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. |
Yu, Liuwen; Fu, Fangmeng; Li, Jing; Huang, Meng; Zeng, Bangwei; Lin, Yuxiang; Mei, Qian; Lv, Jinxing |
|
Mar 31, 2020 |
9224 |
| Somatic Mutations in HER2 and Implications for Current Treatment Paradigms in HER2-Positive Breast Cancer. |
Gaibar, Maria; Beltran, Laura; Romero-Lorca, Alicia; Fernandez-Santander, Ana; Novillo, Apolonia |
|
Mar 31, 2020 |
9336 |
| Th17 Cells and IL-17 As Novel Immune Targets in Ovarian Cancer Therapy. |
Bilska, Monika; Pawlowska, Anna; Zakrzewska, Ewelina; Chudzik, Agata; Suszczyk, Dorota; Gogacz, Mare |
|
Mar 31, 2020 |
9245 |
| Treatment Patterns and Healthcare Resource Utilization among Patients with Advanced or Metastatic Soft Tissue Sarcoma in US Community Practices. |
Nadler, Eric; Aguilar, Kathleen; Wentworth, Chuck; Boyd, Marley; Amirian, E. Susan; Barker, Scott; F |
Clinical report |
Mar 31, 2020 |
7452 |
| Ifosfamide, Carboplatin, and Etoposide (ICE) in Combination with Regional Hyperthermia as Salvage Therapy in Patients with Locally Advanced Nonmetastatic and Metastatic Soft-Tissue Sarcoma. |
Bucklein, Veit; Limmroth, Christina; Kampmann, Eric; Schuebbe, Gesa; Issels, Rolf; Roeder, Falk; Ang |
|
Mar 31, 2020 |
6140 |
| High Hydrostatic Pressure Therapy Annihilates Squamous Cell Carcinoma in a Murine Model. |
Mitsui, Toshihito; Morimoto, Naoki; Mahara, Atsushi; Notodihardjo, Sharon Claudia; Le, Tien Minh; Mu |
|
Mar 31, 2020 |
4893 |
| Homology Modeling and Virtual Screening Studies of Antigen MLAA-42 Protein: Identification of Novel Drug Candidates against Leukemia--An In Silico Approach. |
Shehadi, Ihsan A.; Rashdan, Huda R.M.; Abdelmonsef, Aboubakr H. |
|
Mar 31, 2020 |
5664 |
| Response to Dabrafenib and Trametinib of a Patient with Metaplastic Breast Carcinoma Harboring a BRAF V600E Mutation. |
Seo, Takuji; Noguchi, Emi; Yoshida, Masayuki; Mori, Taisuke; Tanioka, Maki; Sudo, Kazuki; Shimomura, |
|
Mar 31, 2020 |
3133 |
| Use of KRD-PACE as Salvage Therapy in Aggressive, Relapsed/ Bortezomib-Refractory Extramedullary Multiple Myeloma: A Report of Two Cases and Literature Review. |
Parrondo, Ricardo D.; Roy, Vivek; Sher, Taimur; Alegria, Victoria; Chanan-Khan, Asher A.; Ailawadhi, |
|
Mar 31, 2020 |
3985 |
| Exelixis says Takeda Pharmaceutical receives approval in Japan for CABOMETYX. |
|
|
Mar 25, 2020 |
321 |
| Exelixis Partner Takeda Receives Approval in Japan for Cabometyx Tablets for the Treatment of Curatively Unresectable or Metastatic Renal Cell Carcinoma. |
|
|
Mar 25, 2020 |
649 |
| New i Data On Ex-V vo FC21 Expanded NKCell Therapy In 13 Leukemia Patients. |
|
|
Mar 23, 2020 |
316 |
| African American Men with Advanced Prostate Cancer Treated with Provenge Live Longer than Caucasian Men, Study Shows. |
|
|
Mar 18, 2020 |
649 |
| InxMed (Shanghai) doses first patient in Phase Ib clinical trial of cancer drug IN10018. |
|
|
Mar 17, 2020 |
203 |
| InxMed (Shanghai) doses first patient in Phase Ib clinical trial of cancer drug IN10018. |
|
|
Mar 17, 2020 |
199 |
| AstraZeneca provides update on phase III GY004 trial for cediranib in platinum-sensitive relapsed ovarian cancer. |
|
|
Mar 13, 2020 |
478 |
| AstraZeneca provides update on phase III GY004 trial for cediranib in platinum-sensitive relapsed ovarian cancer. |
|
|
Mar 13, 2020 |
479 |
| AstraZeneca provides update on phase III GY004 trial for cediranib in platinum-sensitive relapsed ovarian cancer. |
|
|
Mar 13, 2020 |
474 |
| AstraZeneca's Lynparza, Cediranib Trial Fails To Meet Primary Endpoint. |
|
|
Mar 12, 2020 |
206 |
| Phase 3 GY004 for Cediranib and Lynparza in Platinum-Sensitive Relapsed Ovarian Cancer Did Not Meet the Primary Endpoint. |
|
|
Mar 12, 2020 |
332 |
| Sentencing raider to jail 'like sending him to his death' Court: Sheriff asks why cancer drugs withheld. |
JAMES WYLLIE |
|
Mar 11, 2020 |
421 |
| The 10-speed cancer therapy: Bike exercise. |
|
|
Mar 3, 2020 |
1597 |
| Samsung Biologics partners with STCube for development and manufacture of novel target anticancer drug STT-003. |
|
|
Mar 3, 2020 |
200 |
| Samsung Biologics partners with STCube for development and manufacture of novel target anticancer drug STT-003. |
|
|
Mar 3, 2020 |
204 |
| Molecular Testing of Lung Cancers--A Summary of What, Why and How. |
Brunstein, John |
|
Mar 1, 2020 |
1461 |
| Efficacy of Palbociclib and Endocrine Treatment in Heavily Pretreated Hormone Receptor-positive/HER2-negative Advanced Breast Cancer: Retrospective Multicenter Trial. |
Demir, Atakan; Mandel, Nil Molinas; Paydas, Semra; Demir, Gokhan; Er, Ozlem; Turhal, Nazim Serdal; B |
|
Mar 1, 2020 |
2696 |
| Bellini Duct Carcinoma Misdiagnosed with Urothelial Papillary Carcinoma. |
Khoury, Joey El; Abdessater, Maher; Halabi, Rami; Nasr, Fadi; Boustany, Johnny; Kanbar, Anthony; Hac |
|
Mar 1, 2020 |
2262 |
| Ibrutinib-Induced Vasculitis in a Patient with Metastatic Colon Cancer Treated in Combination with Cetuximab. |
Chi, Jeffrey; Park, Jennifer; Saif, Muhammad Wasif |
|
Mar 1, 2020 |
2251 |
| Fatal Idiopathic Hyperammonemia after Induction Chemotherapy for Acute Myeloid Leukemia. |
Angelo, Christophe; Vincent, Marie-Francoise; Komuta, Mina; Hantson, Philippe; Straetmans, Nicole; B |
|
Mar 1, 2020 |
2701 |
| A Rare Case of Extracavitary Primary Effusion Lymphoma in the Bladder and Ureter. |
Tong, Jiankun; Jadallah, Sana; Rodgers, William H.; Jung, Gabriel; Fulman, Malvina; Swaika, Abhisek |
|
Mar 1, 2020 |
2364 |
| A Case Report with Severe Thrombocytopenia Induced by Axitinib. |
Koksal, Ulkuhan I.; Goffin, Janeiro; Lewis, Brian; Sartor, Oliver A.; Belyaeva, Elizaveta; Socola, F |
|
Mar 1, 2020 |
2552 |
| A Remarkable Remission: Treating HMA Refractory Transforming MDS with Single-Agent Low-Dose Cytarabine Leading to an Ongoing Six-Year OS. |
Palmer, David; Jones, Lydia |
|
Mar 1, 2020 |
2182 |
| Prognostic Value of Functional Assessment of Cancer Therapy-General (FACT-G) in Advanced Non-Small-Cell Lung Cancer Treated with Korean Medicine. |
Jeon, Hyeonjin; Eo, Wankyu; Shim, Bumsang; Kim, Sehyun; Lee, Sookyung |
|
Mar 1, 2020 |
6013 |
| Detection of Fusion Genes Using a Targeted RNA Sequencing Panel in Gastrointestinal and Rare Cancers. |
Lee, Su Jin; Hong, Jung Yong; Kim, Kyung; Kim, Kyoung-Mee; Kang, So Young; Lee, Taeyang; Kim, Seung |
|
Mar 1, 2020 |
4701 |
| Epigenetic Therapy as a Putative Molecular Target to Modulate B Cell Biology and Behavior in the Context of Immunological Disorders. |
da Costa, Thayse Pinheiro; Cheikh, Marcia Cury El-; Carneiro, Katia |
|
Mar 1, 2020 |
9588 |
| High-Dose Toremifene as a Promising Candidate Therapy for Hormone Receptor-Positive Metastatic Breast Cancer with Secondary Resistance to Aromatase Inhibitors. |
Fushimi, Atsushi; Tabei, Isao; Fuke, Azusa; Okamoto, Tomoyoshi; Takeyama, Hiroshi |
|
Mar 1, 2020 |
3666 |
| Shortage of crucial cancer drug blamed on delay to order. |
|
|
Feb 19, 2020 |
726 |
| Spectrum of preneoplastic and Neoplastic lesions of intestine in a tertiary care hospital of Karachi, Pakistan. |
Asma Shabbir, Muhammad Asif Qureshi, Saadia Akram and Talat Mirza |
|
Feb 14, 2020 |
2811 |
| Astex Pharmaceuticals Wins US Food and Drug Administration Acceptance for Review of an NDA for the Combination Oral Hypomethylating Agent Cedazuridine and Decitabine (ASTX727 or oral C-DEC), for the Treatment of MDS and CMML. |
|
|
Feb 14, 2020 |
923 |
| Volastra Therapeutics Launches with USD 12m in Seed Financing to Develop Novel Metastatic Cancer Therapies. |
|
|
Feb 12, 2020 |
380 |
| Metastatic Pancreatic Cancer Drug on Trial. |
|
|
Feb 1, 2020 |
224 |
| Arix Bioscience investee company Autolus publishes encouraging additional data from blood cancer drug study. |
|
|
Jan 31, 2020 |
218 |
| Genprex's tumor suppressor gene TUSC2 is a novel target and biomarker for thyroid cancer therapy, finds researchers. |
|
|
Jan 30, 2020 |
622 |
| NHS in Scotland could use drones to fly cancer drugs to patients on remote islands. |
|
|
Jan 29, 2020 |
567 |
| Exelixis Presents Results for Combination of Cabozantinib and Nivolumab With or Without Ipilimumab in Advanced Hepatocellular Carcinoma. |
|
|
Jan 27, 2020 |
733 |
| Epizyme's Tazemetostat Drug For Epithelioid Sarcoma Gets Accelerated FDA Approval. |
Neer Varshney |
|
Jan 24, 2020 |
355 |
| The Daily Biotech Pulse: FDA Nod For Epizyme, Sonoma Explores Options For Dermatology Business, Roche's Cancer Drug Flunks Study. |
Shanthi Rexaline |
|
Jan 24, 2020 |
809 |
| Cyclica and AUM Biosciences to Partner on Developing Novel Cancer Therapies with Greater Precision and Speed, under Project Nexus. |
|
|
Jan 22, 2020 |
552 |
| New T-cells 'raise prospect of universal cancer therapy'. |
Press Association |
|
Jan 21, 2020 |
641 |
| New killer T-cells raise hopes of 'universal cancer therapy'. |
MARK SMITH Health correspondent mark.smith@walesonline.co.uk |
|
Jan 21, 2020 |
843 |
| T-cell discovery offers hope over 'cancer therapy' Health: Finding may lead to 'universal' treatment. |
NINA MASSEY |
|
Jan 21, 2020 |
325 |
| Killer immune cell discovery raises prospect of 'universal' cancer therapy. |
|
|
Jan 20, 2020 |
530 |
| Pharmacist jailed for selling opiate cancer drugs on black market. |
|
|
Jan 16, 2020 |
308 |
| Clinigen Group agrees cancer drug supply deal. |
|
|
Jan 15, 2020 |
239 |
| Salarius Pharmaceuticals CEO talks through recent achievements for its lead cancer drug candidate. |
|
|
Jan 14, 2020 |
123 |
| Faron Pharmaceuticals says cancer drug trial group has been expanded. |
|
|
Jan 14, 2020 |
330 |
| Clinigen Signs Agreement With Iovance For Supply Of Proleukin. |
|
|
Jan 14, 2020 |
224 |
| A Clinical Study of Cutaneous Manifestations in Patients on Cancer Therapy at a Tertiary Care Hospital. |
Muralidhar, Krishnakanth; Raghupathy, Roopa; Rangarajan, Sudha; Veeraraghavan, Mahalakshmi; Sundaram |
Clinical report |
Jan 13, 2020 |
2604 |
| Brave boy, 6, gets standing ovation from classmates after beating cancer; Heartbreaking scenes were pictured at St Helen Catholic School in Newbury, Ohio, after John Oliver Zippay completed his final round of chemotherapy to fight his leukemia. |
By, Bradley Jolly |
|
Jan 11, 2020 |
330 |
| China Cancer Drugs Market, by Drugs, Cancer (Lung, Stomach, Breast, Esophageal, Liver & Others), Therapy, Companies. |
|
|
Jan 6, 2020 |
817 |
| Study suggests new application for already known anti-cancer drugs. |
ANI |
|
Jan 5, 2020 |
534 |
| Discontinuation of free cancer drugs puts 5000 patients' life at risk Punjab govt fails to clear pending payments. |
|
|
Jan 4, 2020 |
641 |
| Clinical trial suggests halving cancer therapy. |
|
|
Jan 4, 2020 |
161 |
| Scientific study finds additional uses of anti-cancer drugs. |
ANI |
|
Jan 3, 2020 |
270 |
| PPP flays govt for POL price hike, cancer drug shortage. |
|
|
Jan 2, 2020 |
272 |
| The Daily Biotech Pulse: Canadian Approval For Amarin's Vascepa, Innate Pharma's Blood Cancer Drug Accepted For Review In Europe. |
Shanthi Rexaline |
|
Jan 2, 2020 |
848 |
| Innate Pharma Rallies On Acceptance Of European Regulatory Application For Leukemia Drug. |
Shanthi Rexaline |
|
Jan 2, 2020 |
281 |
| New Year Shock: HIV and Cancer Drugs Just Got Pricier Amid Widespread Price Increase. |
Dominic Nicosia |
|
Jan 1, 2020 |
303 |
| Overview of Colon Cancer for the Medical-Surgical Nurse. |
Moe, Linda; Bohnenkamp, Susan |
Medical condition overview |
Jan 1, 2020 |
2309 |
| Correlation between healing type of lesion and recurrence in gastric neoplastic lesions after endoscopic submucosal dissection. |
Cha, Jae Hwang; Jang, Jin Seok |
|
Jan 1, 2020 |
3561 |
| Stage IV Small Lymphocytic Lymphoma Presenting with Unilateral Vision Loss. |
Le, Christopher; Jacob, Adam; Iyengar, Devarajan; Dedousis, John; Tsompanidis, Antonios |
|
Jan 1, 2020 |
2350 |
| Efficacy of Panobinostat for the Treatment of Multiple Myeloma. |
Eleutherakis-Papaiakovou, Evangelos; Kanellias, Nikolaos; Kastritis, Efstathios; Gavriatopoulou, Mar |
|
Jan 1, 2020 |
8809 |
| Exceptional Response of Metastatic Chromophobe Renal Cell Carcinoma to Vascular Endothelial Growth Factor (VEGF) Inhibitors: Should Increased VEGF-C Expression Be Used to Guide Treatment? |
Bruinius, Jacob W.; Dykema, Karl J.; Noyes, Sabrina L.; Teh, Bin Tean; Lane, Brian R. |
|
Jan 1, 2020 |
3400 |
| Correlation between healing type of lesion and recurrence in gastric neoplastic lesions after endoscopic submucosal dissection. |
Cha, Jae Hwang; Jang, Jin Seok |
|
Jan 1, 2020 |
3570 |
| Obesity May Boost Effectiveness of a Lung Cancer Therapy. |
|
|
Dec 30, 2019 |
490 |
| Using a Chip to Find Better Cancer Drugs. |
|
|
Dec 28, 2019 |
458 |
| Cancer drug better for fatter patients; Scientists term it 'obesity paradox'. |
LUCY THORNTON |
|
Dec 27, 2019 |
115 |
| Obesity May Up Cardiotoxicity Risk From Breast Cancer Therapy; Obesity independently associated with treatment-related cardiotoxicity in breast cancer patients. |
|
|
Dec 24, 2019 |
233 |
| Bladder Cancer Drugs Market Research Report, Industry Size, Share, Demand, Price, Top Manufacturers, Growth Analysis & Forecast to 2020 / Radiant Insights, Inc. |
|
Report |
Dec 23, 2019 |
898 |
| Global Blood Cancer Drugs Market Comparison Analysis, Capacity Production, Cost Production Value And Industry Forecasts, 2020 By Radiant Insights, Inc. |
|
Industry overview |
Dec 23, 2019 |
685 |
| AstraZeneca sells rights to breast, prostate cancer drugs for US$181mln. |
|
|
Dec 21, 2019 |
260 |
| 'Tumor-on-a-chip' to revolutionize cancer drug testing. |
ANI |
|
Dec 21, 2019 |
576 |
| Seminar on "Cancer drug development from natural sources: The Neem story" - Press Release issued by Capital University of Science and Technology. |
|
|
Dec 20, 2019 |
304 |
| LONDON MARKET PRE-OPEN: AstraZeneca Sells Cancer Drug Rights. |
|
|
Dec 20, 2019 |
825 |
| AstraZeneca Sells Two Cancer Drug Rights For Up To USD198 Million. |
|
|
Dec 20, 2019 |
212 |
| Bridgebio files lung cancer drug trial plans in US, Korea. |
|
|
Dec 20, 2019 |
286 |
| Low cost breast cancer medicine move good news for women: UN health agency. |
|
|
Dec 19, 2019 |
377 |
| The Daily Biotech Pulse: Seattle Genetics' Bladder Cancer Drug Gets FDA Nod, Paratek Wins Contract For Antibiotic. |
Shanthi Rexaline |
|
Dec 19, 2019 |
1288 |
| China $30+ Billion Cancer Drugs Market to 2025 by Drugs, Cancer (Lung, Stomach, Breast, Esophageal, Liver & Others), Therapy, Companies. |
|
|
Dec 18, 2019 |
608 |
| Thyroid Cancer Drugs Global Market 2020: Top Players, Region, Revenue, Trends, Application and Sales Channel Report / Radiant Insights, Inc. |
|
Financial report |
Dec 18, 2019 |
872 |
| Cancer Drug Shows Promise for Parkinson's Patients. |
Steven Reinberg, HealthDay Reporter |
|
Dec 16, 2019 |
689 |
| AstraZeneca and Daiichi Sankyo reveal positive data from trastuzumab deruxtecan Phase II single-arm DESTINY-Breast01 trial. |
|
|
Dec 13, 2019 |
234 |
| AstraZeneca and Daiichi Sankyo reveal positive data from trastuzumab deruxtecan Phase II single-arm DESTINY-Breast01 trial. |
|
|
Dec 13, 2019 |
238 |
| Hillstream BioPharma harnassing the body's immune system to improve cancer drug delivery. |
|
|
Dec 12, 2019 |
109 |
| Parents refuse cancer drugs in favour of cannabis oil for baby. |
MARK SMITH Health Correspondent mark.smith@walesonline.co.uk |
|
Dec 12, 2019 |
682 |
| Parents refuse cancer drugs in favour of cannabis for sick son. |
MARK SMITH Health correspondent mark.smith@walesonline.co.uk |
|
Dec 12, 2019 |
1186 |
| Global Cervical Cancer Drugs Market Report 2020: Market was Valued $15.3 Billion in 2018 and is Expected to Grow to $17.9 billion Through 2022. |
|
Report |
Dec 11, 2019 |
915 |
| Global Brain Tumor Drugs Market Report 2020: Focus on Temozolomide, Carmustine, Cisplatin, Bevacizumab, Geftinib, Erlotinib. |
|
Report |
Dec 11, 2019 |
983 |
| Global Blood Cancer Drugs Market Report 2020: Focus on Rituaxan/Mabthera, Gleevac/Glivec, Revlimid, Velcade, Tasigna, Pomalyst, Vidaza, Kyprolis Adcetris. |
|
Report |
Dec 11, 2019 |
1128 |
| Global Bladder Cancer Drugs Market Report 2020: Focus on Non-Muscle-Invasive Bladder Cancer & Muscle-Invasive Bladder Cancer. |
|
Report |
Dec 11, 2019 |
954 |
| Global Gastric Cancer Drugs Market Report 2020: Focus on Doxorubicin Hydrochloride, Sunitinib, Docetaxel, Mitomycin, Fluorouracil, Imatinib, Trastuzumab. |
|
Report |
Dec 11, 2019 |
896 |
| Global Thyroid Cancer Drugs Market Report 2020: Focus on Ipilimumab, Cabozantinib-S-Malate, Caprelsa, Doxorubicin Hydrochloride, Lenvatinib Mesylate, Nivolumab, Vandetanib. |
|
Report |
Dec 11, 2019 |
783 |
| Global Kidney Cancer Drugs Market Report 2020: Focus on Nexavar, Sutent, Afinitor, Votrient, Avastin, Inlyta, Torisel, Proleukin. |
|
Report |
Dec 11, 2019 |
989 |
| Medicenna Therapeutics completes Phase 2B study on cancer drug mdna55. |
|
|
Dec 11, 2019 |
121 |
| Go-ahead for ovarian cancer drug; HEALTH. |
|
|
Dec 10, 2019 |
167 |
| Singh Biotechnology's low-cost virtual company model advances cancer therapies rapidly. |
|
|
Dec 10, 2019 |
142 |
| Edinburgh mum welcomes life-prolonging ovarian cancer drug which has given her 'new lease of life'. |
|
|
Dec 9, 2019 |
634 |
| Charity plea over ovarian cancer drug for ill Scots; Ruling today on vital medicine. |
JOHN DINGWALL |
|
Dec 9, 2019 |
157 |
| Global Cancer Immunotherapy Market: $100+ Billion Analysis & Forecast 2020-2023. |
|
|
Dec 4, 2019 |
1496 |
| Bobrek ve Mesane Tumorlerinde PET/BT'nin Klinik Kullanimi/The Use of F-18-FDG PET/CT in Renal and Bladder Tumors. |
Akkas, Burcu Esen |
|
Dec 1, 2019 |
3807 |
| TLR9 agonist may overcome resistance to anti-PD-1 melanoma therapy. |
Smith, Jennifer |
|
Dec 1, 2019 |
422 |
| Retrospective analysis of efficacy, safety, and prognostic factors in a cohort of Chinese hepatocellular carcinoma patients treated with drug-eluting bead transarterial chemoembolization. |
Chen, Sihan; Ji, Rengbin; Shi, Xiaojun; Wang, Zhe; Zhu, Dedong |
|
Dec 1, 2019 |
4770 |
| Bioinformatics Analysis of Potential Key Genes in Trastuzumab-Resistant Gastric Cancer. |
Yang, Guangda; Jian, Liumeng; Lin, Xiangan; Zhu, Aiyu; Wen, Guohua |
|
Dec 1, 2019 |
5318 |
| Sporadic Medullary Thyroid Carcinoma with Paraneoplastic Cushing Syndrome. |
Pivovarova, Aleksandra I.; Patrick, Stephanie; Reddy, Punuru J. |
|
Dec 1, 2019 |
2064 |
| Dramatic Response to First Line Single Agent Pembrolizumab in Anaplastic Thyroid Carcinoma. |
Spalart, Valerie; Legius, Barbara; Segers, Kurt; Coolen, Johan; Maes, Brigitte; Decoster, Lynn |
|
Dec 1, 2019 |
1790 |
| Unique Case Report of a Meningeal Sarcoma Arising during Ongoing Treatment for Progressing Intraparenchymal Glioma. |
Petersons, Richard A.; Kashyap, Bhavani; Pawloski, Pamala A.; Forsberg, Anna C.; Hanson, Leah R. |
|
Dec 1, 2019 |
4408 |
| Severely Disseminated Kaposi Sarcoma after ABO-Incompatible Kidney Transplantation Treated Successfully with Paclitaxel and Gemcitabine Combined with Hemodialysis. |
Bomholt, Tobias; Krarup-Hansen, Anders; Egfjord, Martin; Sorensen, Soren Schwartz; Junker, Niels |
|
Dec 1, 2019 |
1557 |
| Combination with Stereotactic Body Radiotherapy Offers a Promising Strategy to Overcome Resistance to Immunotherapy in Advanced Renal Cell Cancer. |
Sun, Xiaowen; Gan, Lu; Na, Aru; Ge, Lingling; Chen, Baoqing; Liu, Jiaming |
|
Dec 1, 2019 |
9231 |
| Successes and Challenges for Diagnosis and Therapy of Acute Leukemia. |
Lonetti, Annalisa; Iacobucci, Ilaria; Masetti, Riccardo |
|
Dec 1, 2019 |
915 |
| Innovation in Oncology Drug Development. |
Huber, Matthew; Huber, Brian |
|
Dec 1, 2019 |
12396 |
| Molecular Mechanism of Matrine from Sophora alopecuroides in the Reversing Effect of Multi-Anticancer Drug Resistance in K562/ ADR Cells. |
Chen, Zhi; Nishimura, Nobuhiro; Okamoto, Takayuki; Wada, Koichiro; Naora, Kohji |
|
Dec 1, 2019 |
5600 |
| A Pharmacokinetic Interaction Study of Sorafenib and Iced Teas in Rats Using UPLC-MS/MS: An Illustration of Beverage-Drug Interaction. |
Maher, Hadir M.; Almomen, Aliyah; Alzoman, Nourah Z.; Shehata, Shereen M.; Subaie, Amal Al- |
|
Dec 1, 2019 |
8744 |
| Systemic Pharmacological Approach to Identification and Experimental Verification of the Effect of Anisi Stellati Fructus Extract on Chronic Myeloid Leukemia Cells. |
Kim, Youn Sook; Suh, Su Yeon; Ahn, Yong Tae; Lee, Chul Won; Lee, Sang Yull; Ahn, Soon Cheol; An, Won |
|
Dec 1, 2019 |
7565 |
| AstraZeneca cancer drug fast-tracked by the FDA. |
|
|
Nov 30, 2019 |
188 |
| Breast Cancer Drugs Market 2019- Global Industry Analysis, By Key Players, Trends and Forecast By 2026. |
|
|
Nov 27, 2019 |
681 |
| Kidney Cancer Drugs Market - Asia Pacific To Register The Highest CAGR During 2018-2022. |
|
|
Nov 26, 2019 |
684 |
| AstraZeneca gains US FDA approval for lymphocytic cancer drug Calquence. |
|
|
Nov 25, 2019 |
216 |
| Anti-Neoplastic Agents Market Outlook To 2022: Top Players, Growth Analysis, Industry Size, Regions, Global Opportunity, Demand, Competitive Share Overview and Emerging Trends. |
|
|
Nov 25, 2019 |
866 |
| AstraZeneca gains US FDA approval for lymphocytic cancer drug Calquence. |
|
|
Nov 25, 2019 |
212 |
| MaxCyte inks licensing deal with cutting-edge US cancer drug developer. |
|
|
Nov 22, 2019 |
216 |
| Kidney/Renal Cancer Drugs Market Comprehensive Analysis: Check Latest Strategic Moves of Emerging Players. |
|
|
Nov 22, 2019 |
1047 |
| Cancer drugs. |
Dr Nasir Ahmad - Karachi |
|
Nov 22, 2019 |
285 |
| A factory to produce Syria's first manufactured anticancer drugs inaugurated. |
shaza |
|
Nov 21, 2019 |
243 |
| Thyroid Cancer Drugs Market To Grow At A CAGR Of 17.7% During 2018-2022. |
|
|
Nov 21, 2019 |
933 |
| CytoDyn reveals its drug inhibits colon carcinoma metastases to liver and lung in preclinical study. |
|
|
Nov 20, 2019 |
127 |
| Oscar, 5, flying out for PS500k cancer therapy. |
KAREN ROCKETT |
|
Nov 17, 2019 |
155 |
| The Daily Biotech Pulse: Amarin Gets Unanimous Backing For Vascepa Expansion, BeiGene's Blood Cancer Drug Gets Approval. |
Shanthi Rexaline |
|
Nov 15, 2019 |
1538 |
| Breckenridge wins final FDA approval for launch of generic Tarceva. |
|
|
Nov 13, 2019 |
157 |
| Breckenridge wins final FDA approval for launch of generic Tarceva. |
|
|
Nov 13, 2019 |
153 |
| Paragraph IV Patent Certifications Winners and Losers Monthly Report. |
|
Report |
Nov 11, 2019 |
347 |
| Small cap movers: Faron Pharma rockets as its rakes in more funds to bankroll new cancer drug. |
|
|
Nov 10, 2019 |
753 |
| Faron Pharma cash injection will fund development of cancer drug. |
|
|
Nov 9, 2019 |
350 |
| Global Neuroendocrine Tumors (NETs) Market Insights, Epidemiology and Market Forecasts, 2017-2018 & 2019-2028. |
|
|
Nov 7, 2019 |
1126 |
| 2019 Innovations in Wound Management, Cancer Therapy, Cardiac Diagnostics, and Women's Health. |
|
|
Nov 7, 2019 |
574 |
| Blood Cancer Drugs Market - APAC To Register Highest CAGR During 2018-2023. |
|
|
Nov 6, 2019 |
556 |
| Bristol-Myers Squibb (NYSE: BMY). |
|
|
Nov 4, 2019 |
1776 |
| I can now watch my baby grow up thanks to YOU; Mum praises kind readers for funding her pioneering cancer drugs. |
EXCLUSIVE by Geraldine McKelvie EXCL |
|
Nov 3, 2019 |
951 |
| WHICH PATIENTS WILL BENEFIT MOST FROM DOCETAXEL ADDITION TO ANDROGEN DEPRIVATION THERAPY (ADT) IN METASTATIC CASTRATE-SENSITIVE PROSTATE CANCER (MCSPC)?/U KOJIH BOLESNIKA PRIMIJENITI HORMONSKU TER APIJU + DOCETAKSEL. |
Gamulin, Marija; Bebek, Marko; Gnjidic, Milena |
Disease/Disorder overview |
Nov 1, 2019 |
1082 |
| CHALLENGES IN MANIPULATING IMMUNE SYSTEM TO TREAT PROSTATE CANCER/IZAZOVI MANIPULIRANJA IMUNOLOSKIM SUSTAVOM U SVRHU LIJECENJA RAKA PROSTATE. |
Samija, Ivan; Frobe, Ana |
|
Nov 1, 2019 |
3409 |
| What Medical-Surgical Nurses Need to Know About Caring for Patients with Epithelial Ovarian Cancer: Part II. |
Bohnenkamp, Susan; McClung, Emily; Bohnenkamp, Zachary |
|
Nov 1, 2019 |
4241 |
| Highly Aggressive CD4-Positive Mast Cell Leukaemia (Leukaemic Variant) Associated with Isolated Trisomy 19 and Hemophagocytosis by Neoplastic Mast Cells: A Case Report with Challenging Experience and Review. |
Soliman, Dina Sameh; Al-Sabbagh, Ahmad; Ibrahim, Feryal; Gameil, Amna; Yassin, Mohamed; El-Omri, Hal |
|
Nov 1, 2019 |
4762 |
| Acute Immune-Mediated Thrombocytopenia due to Oxaliplatin and Irinotecan Therapy. |
Tam, Eric L.; Draksharam, Padma L.; Park, Jennifer A.; Sidhu, Gurinder S. |
|
Nov 1, 2019 |
3129 |
| The Role of Immunotherapy in Extensive Stage Small-Cell Lung Cancer: A Review of the Literature. |
Tsiouprou, Ioanna; Zaharias, Athanasios; Spyratos, Dionisios |
|
Nov 1, 2019 |
5174 |
| As Clinical Markers, Hand-Foot-Skin Reaction and Diarrhea Can Predict Better Outcomes for Hepatocellular Carcinoma Patients Receiving Transarterial Chemoembolization plus Sorafenib. |
Liu, Lei; Wang, Enxin; Li, Lin; Chen, Dongyu; Peng, Kun; Wang, Mengmeng; Han, Guohong |
|
Nov 1, 2019 |
5098 |
| Targeting L-Lactate Metabolism to Overcome Resistance to Immune Therapy of Melanoma and Other Tumor Entities. |
Feichtinger, Renie G.; Lang, Roland |
|
Nov 1, 2019 |
9518 |
| Implications for Tumor Microenvironment and Epithelial Crosstalk in the Management of Gastrointestinal Cancers. |
Ge, Yang; Westphalen, C. Benedikt; Ma, Wen Wee; Vega, Kenneth J.; Weygant, Nathaniel |
Disease/Disorder overview |
Nov 1, 2019 |
9178 |
| Monoclonal Antibody Therapies in Multiple Myeloma: A Challenge to Develop Novel Targets. |
Nishida, Hiroko; Yamada, Taketo |
|
Nov 1, 2019 |
7486 |
| Developments in Platinum-Group Metals as Dual Antibacterial and Anticancer Agents. |
Odularu, Ayodele T.; Ajibade, Peter A.; Mbese, Johannes Z.; Oyedeji, Opeoluwa O. |
|
Nov 1, 2019 |
11310 |
| Yu Ping Feng San Exert Anti-Angiogenesis Effects through the Inhibition of TSLP-STAT3 Signaling Pathways in Hepatocellular Carcinoma. |
Yuan, Qin; Yao, Fei; Zhou, Liang; Liang, Guoqiang; Song, Xiudao; Jiang, Guorong; Zhou, Man; Zhang, L |
|
Nov 1, 2019 |
8860 |
| Upregulation of miR-129-5p increases the sensitivity to Taxol through inhibiting HMGB1-mediated cell autophagy in breast cancer MCF-7 cells. |
Shi, Ying; Gong, Weihua; Lu, Lu; Wang, Yunfeng; Ren, Jingjing |
|
Nov 1, 2019 |
4938 |
| The Pretherapeutic Neutrophil-to-Lymphocyte Ratio for Docetaxel-Based Chemotherapy Is Useful for Predicting the Prognosis of Japanese Patients with Castration-Resistant Prostate Cancer. |
Tatenuma, Tomoyuki; Kawahara, Takashi; Hayashi, Narihiko; Hasumi, Hisashi; Makiyama, Kazuhide; Nakai |
|
Nov 1, 2019 |
3069 |
| Simultaneous Determination of Etoposide and Paclitaxel in Biological and Pharmaceutical Samples by RP-HPLC; Method Development, Validation and Applications of the method for Evaluation of Polymeric Nanoparticles. |
|
Report |
Oct 31, 2019 |
7414 |
| Recovery of Chemotherapy-induced Anemia by Angelica Polysaccharides in C57BL/6N Mice and Elucidation of Underlying Mechanism. |
Zhao, Tian-Yi; Liu, Zi-Qing; Yang, Bo; Gao, Qiao; Zhang, Hong-Yu; He, Pei-Yu; Duan, Ming-Hua; Yan, Y |
Report |
Oct 31, 2019 |
4065 |
| Celgene Corporation (NASDAQ: CELG). |
|
|
Oct 30, 2019 |
2404 |
| Bristol Myers Squibb UK. |
|
|
Oct 29, 2019 |
1786 |
| Pfizer raises 2019 forecast as sales of cancer drug, heart medicine surge. |
Reuters News Service |
|
Oct 29, 2019 |
448 |
| Deciphera saus rebastinib, paclitaxel combination showed 'encouraging' activity. |
|
|
Oct 28, 2019 |
264 |
| AstraZeneca's Triple Combo Lung Cancer Therapy Aces Late-Stage Trial. |
Shanthi Rexaline |
|
Oct 28, 2019 |
471 |
| Abbvie (NYSE: ABBV). |
|
|
Oct 28, 2019 |
2885 |
| Bristol-Myers Squibb (NYSE:BMY). |
|
|
Oct 28, 2019 |
1781 |
| FDA clears NuCana's IND for study of Acelarin in combination with cisplatin. |
|
|
Oct 25, 2019 |
203 |
| BOC Sciences to Release EGFR Inhibitors for the Science Community of Cancer Treatment Research. |
|
|
Oct 24, 2019 |
648 |
| Tilray Backs First Human Study On Medical Marijuana Used For Breast Cancer Drug Side Effects. |
Nina Zdinjak |
|
Oct 24, 2019 |
376 |
| Midatech Pharma Childhood Cancer Drug Given FDA Orphan Designation. |
|
|
Oct 24, 2019 |
187 |
| Seattle Genetics (NASDAQ: SGEN) - Seattle Genetics Announces Positive Topline Results from Pivotal Trial of Tucatinib in Locally Advanced or Metastatic HER2-Positive Breast Cancer -- 21/10/2019. |
|
|
Oct 24, 2019 |
2019 |
| Celgene Corporation (NASDAQ: CELG). |
|
|
Oct 24, 2019 |
2446 |
| Let melanoma patients have this cancer drug it's keeping me alive; Mum-of-three's plea to Leo over funding. |
LOUISE WALSH |
|
Oct 23, 2019 |
332 |
| Propanc Biopharma plans to advance clinical trials on lead cancer drug PRP. |
|
|
Oct 22, 2019 |
407 |
| Propanc Biopharma plans to advance clinical trials on lead cancer drug PRP. |
|
|
Oct 22, 2019 |
409 |
| Bristol Myers Squibb UK. |
|
|
Oct 22, 2019 |
1781 |
| Abbvie (NYSE: ABBV). |
|
|
Oct 21, 2019 |
2885 |
| Bristol-Myers Squibb (NYSE:BMY). |
|
|
Oct 21, 2019 |
1781 |
| US FDA accepts Biologics License Application for AstraZeneca's and Daiichi Sankyo's trastuzumab deruxtecan for review. |
|
|
Oct 21, 2019 |
169 |
| US FDA accepts Biologics License Application for AstraZeneca's and Daiichi Sankyo's trastuzumab deruxtecan for review. |
|
|
Oct 21, 2019 |
165 |
| AstraZeneca and Daiichi Sankyo report trastuzumab deruxtecan granted US FDA Priority Review. |
|
|
Oct 18, 2019 |
291 |
| AstraZeneca and Daiichi Sankyo report trastuzumab deruxtecan granted US FDA Priority Review. |
|
|
Oct 18, 2019 |
287 |
| United States Cancer Drugs Market Prospects, Trends Analysis, Market Size and Forecasts up to 2024. |
|
|
Oct 17, 2019 |
577 |
| AstraZeneca Shares Trade Higher After FDA Grants Breast Cancer Drug Priority Review. |
Shanthi Rexaline |
|
Oct 17, 2019 |
421 |
| TOP NEWS: AstraZeneca Breast Cancer Drug Granted US Priority Review. |
|
|
Oct 17, 2019 |
184 |
| Celgene Corporation (NASDAQ: CELG). |
|
|
Oct 17, 2019 |
2403 |
| Sareum looks towards clinical studies for novel autoimmune and cancer therapies. |
|
Clinical report |
Oct 16, 2019 |
285 |
| Roche meets primary endpoint in phase three PEMPHIX trial of MabThera. |
|
|
Oct 15, 2019 |
209 |
| Roche meets primary endpoint in phase three PEMPHIX trial of MabThera. |
|
|
Oct 15, 2019 |
205 |
| Bristol Myers Squibb UK. |
|
|
Oct 15, 2019 |
1781 |
| Abbvie (NYSE: ABBV). |
|
|
Oct 14, 2019 |
2373 |
| Bristol-Myers Squibb (NYSE: BMY). |
|
|
Oct 14, 2019 |
1776 |
| Celgene Corporation (NASDAQ: CELG). |
|
|
Oct 9, 2019 |
2219 |
| Bristol Myers Squibb UK. |
|
|
Oct 8, 2019 |
1781 |
| Suspension of free cancer medicines: health secy summoned. |
|
|
Oct 8, 2019 |
260 |
| More cancer drugs confirmed - even more on horizon. |
|
|
Oct 7, 2019 |
310 |
| Anti Neoplastic Agents Market Growth, Size, Top Key Players Share Analysis, Demand Overview, Import & Export and Revenue Status, Business Forecast To 2022. |
|
|
Oct 7, 2019 |
969 |
| Bristol-Myers Squibb (NYSE: BMY). |
|
|
Oct 7, 2019 |
1781 |
| Banned tanning products on sale on Tyneside streets, BBC investigation reveals; Barber shops and beauty salons in County Durham and Tyneside were among the places Inside Out reporters were able to purchase products containing Melanotan, an unlicensed medication. |
Hannah Graham |
|
Oct 6, 2019 |
425 |
| Q BioMed in partnership deal to distribute non-opioid metastatic cancer drug in US. |
|
|
Oct 4, 2019 |
454 |
| NHS denied use of cancer drug; UK & WORLD. |
|
|
Oct 3, 2019 |
147 |
| NHS denied use of cancer drug; UK & WORLD. |
|
|
Oct 3, 2019 |
147 |
| The Daily Biotech Pulse: IPOs, Puma's Breast Cancer Drug Gets Label Expansion, Buyout Offer For Organovo. |
Shanthi Rexaline |
|
Oct 3, 2019 |
1185 |
| Celgene Corporation (NASDAQ: CELG). |
|
|
Oct 2, 2019 |
2266 |
| Bristol Myers Squibb UK. |
|
|
Oct 2, 2019 |
1786 |
| Abbvie (NYSE: ABBV). |
|
|
Oct 1, 2019 |
2373 |
| Bristol-Myers Squibb (NYSE: BMY). |
|
|
Oct 1, 2019 |
1781 |
| Raymond James Upgrades Zymeworks, Says Encouraging Cancer Drug Is 'Born to Run'. |
Dave Royse |
|
Oct 1, 2019 |
486 |
| US FDA approves Roche's Rituxan in combination with Glucocorticoids. |
|
|
Oct 1, 2019 |
272 |
| US FDA approves Roche's Rituxan in combination with Glucocorticoids. |
|
|
Oct 1, 2019 |
268 |
| Rituxan Approved for Pediatric Patients With Rare Vasculitis Diseases; Approval of Rituxan expanded to children with granulomatosis with polyangiitis, microscopic polyangiitis. |
|
|
Oct 1, 2019 |
300 |
| Nanovectors Design for Theranostic Applications in Colorectal Cancer. |
Rampado, Riccardo; Crotti, Sara; Caliceti, Paolo; Pucciarelli, Salvatore; Agostini, Marco |
|
Oct 1, 2019 |
16875 |
| Astrazeneca and GSK to release new cancer drug. |
LUDWIG BURGER |
Drug overview |
Sep 30, 2019 |
341 |
| The FDA approves the first treatment Rituxan for children with GPA and MPA. |
|
|
Sep 30, 2019 |
222 |
| The FDA approves the first treatment Rituxan for children with GPA and MPA. |
|
|
Sep 30, 2019 |
218 |
| The Week Ahead In Biotech (Sept. 29-Oct. 5): Conference Presentations, IPOs Hit Top Gear. |
Shanthi Rexaline |
Calendar |
Sep 29, 2019 |
1422 |
| Calithera Biosciences presents data from randomized Phase 2 ENTRATA study. |
|
Clinical report |
Sep 29, 2019 |
493 |
| Sareum Holdings to showcase potential of new cancer drug at leading industry conference. |
|
Conference news |
Sep 28, 2019 |
235 |
| Cancer drug hope at university. |
|
|
Sep 27, 2019 |
186 |
| Discover Global Kidney Cancer Drugs Market Upcoming Trends, Growth Drivers and Challenges - Forecast to 2025. |
|
|
Sep 27, 2019 |
725 |
| FDA approves Genentech's Rituxan. |
|
|
Sep 27, 2019 |
229 |
| Renal Cell Carcinoma Drugs Market: 2019 Global Industry Outlook, Size, Share, Growth Insights, Top Key Players, Emerging Trends and 2028 Forecast. |
|
Industry overview |
Sep 26, 2019 |
1329 |
| Celgene Corporation (NASDAQ: CELG). |
|
|
Sep 25, 2019 |
2266 |
| Bristol Myers Squibb UK. |
|
|
Sep 24, 2019 |
1786 |
| Faron Pharma in talks to find partner for lead cancer drug. |
|
|
Sep 24, 2019 |
366 |
| Delhi: AATS busts racket selling cancer medicines meant for sale in Defence, ESI. |
ANI |
|
Sep 23, 2019 |
260 |
| Bristol-Myers Squibb (NYSE:BMY). |
|
|
Sep 23, 2019 |
1713 |
| Leukemia drug may treat brain cancer in children: Study. |
ANI |
|
Sep 21, 2019 |
357 |
| Case Study of TK216 in Ewing Sarcoma Given at the Children's Oncology Group Meeting. |
|
|
Sep 20, 2019 |
617 |
| Maxcyte keen to broaden reach of cancer drug platform Carma. |
|
|
Sep 19, 2019 |
261 |
| Celgene Corporation (NASDAQ: CELG). |
|
|
Sep 19, 2019 |
2224 |
| Bristol Myers Squibb UK. |
|
|
Sep 18, 2019 |
1621 |
| Head And Neck Cancer Drugs Market To Project Lucrative Growth Due To Rising Number of Patients And High Demand For Cost-Efficient Treatment Options Till 2022 / Million Insights. |
|
|
Sep 18, 2019 |
915 |
| Abbvie (NYSE: ABBV). |
|
|
Sep 17, 2019 |
2373 |
| Bristol-Myers Squibb (NYSE:BMY). |
|
|
Sep 17, 2019 |
1718 |
| Celgene Corporation (NASDAQ: CELG). |
|
|
Sep 12, 2019 |
2266 |
| Ipsen - Ipsen and Servier announce initial Phase II/III clinical data evaluating investigational liposomal irinotecan (ONIVYDE[R]) as a second-line treatment for small cell lung cancer (SCLC) at the IASLC 2019 World Conference on Lung Cancer - 8/9/2019. |
|
Conference news |
Sep 11, 2019 |
619 |
| Bristol-Myers Squibb (NYSE:BMY). |
|
|
Sep 11, 2019 |
1718 |
| Bristol Myers Squibb UK. |
|
|
Sep 11, 2019 |
1621 |
| Cancer Drugs Sometimes Work in Unexpected Ways: Study. |
|
Report |
Sep 11, 2019 |
379 |
| GSK to present data from its innovative oncology portfolio at ESMO Congress 2019. |
|
|
Sep 10, 2019 |
1035 |
| Novadoz Pharmaceuticals awarded FDA clearance for Fosaprepitant and Decitabine generics. |
|
|
Sep 6, 2019 |
197 |
| Strategy to boost cancer medicines with "Lazarus effect". |
|
|
Sep 6, 2019 |
1187 |
